A Prospective Clinical Trial to Evaluate the Efficacy and Safety of Neurotropic B-Vitamins in Clinically Diagnosed Peripheral Sensory Polyneuropathy of Different Etiologies.
Study sponsor: Procter and Gamble
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-11-02Actual
Enrollment · participants323Actual
Source updated2023-11-28Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.